Pricing Log in Create free account
Saturday 17 October 2026 Export BAX’s income statement to Excel — free account

Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024. In the quarter to June 2026, revenue grew 5.34%, EPS grew 33.3%, free cash flow grew 119.5% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

25.33 0.43 −1.67%
Market cap
$13.3B
P/E
0.0×
Fwd P/E
44.7×
Dividend yield
0.16%
F-score
4/9
Altman Z
2.12
Beneish M
−2.67
Dividend safety
0/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Baxter International Inc. (BAX) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Baxter International Inc. (BAX) trades at a EV/EBITDA of 14.0×. Over the past ten years it has ranged from 10.2× (March 2015) to 45.0× (December 2023); the current reading is higher than 11% of that period. That is in line with the Medical Instruments & Supplies industry median of 14.6× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 12.0× (32.27%)
FY2024 17.7× (1.59%)
FY2023 17.9× (38.95%)
FY2022 29.4× 12.72%
FY2021 26.1× 47.87%
FY2020 17.6× 2.52%
FY2019 17.2× 10.07%
FY2018 15.6× (12.98%)
FY2017 18.0× 14.41%
FY2016 15.7× (5.28%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 12.6× 13.25%
Mar 2026 11.1× (6.89%)
Dec 2025 12.0× (11.18%)
Sep 2025 13.5× (16.57%)
42 more quarters

Against its own ten years

Low 10.2× High 45.0×
Ten-year median 17.7×
Current reading's percentile 11

EV/EBITDA against peers

Company EV/EBITDA
SOLV Solventum Corporation compare 7.6×
ATR AptarGroup, Inc. compare 11.6×
ALGN Align Technology, Inc. compare 11.8×
BAX Baxter International Inc. 14.0×
BLCO Bausch + Lomb Corporation compare 14.1×
COO The Cooper Companies, Inc. compare 14.6×
WST West Pharmaceutical Services, Inc. compare 31.2×
RGEN Repligen Corporation compare 60.2×
AVTR Avantor, Inc. compare 116×
Medical Instruments & Supplies industry median 14.6×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on BAX